Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06078865 · ClinicalTrials.gov registry record
FX Shoulder Prospective Clinical Study
A clinical trial of Osteoarthritis Shoulder and Rotator Cuff Syndrome of Shoulder and Allied Disorders, sponsored by FX Shoulder Solutions.
- Recruiting
- Registry status
- 600
- Enrollment target
- 4
- Study locations
NCT06078865: Recruiting study of Osteoarthritis Shoulder and Rotator Cuff Syndrome of Shoulder and Allied Disorders, sponsored by FX Shoulder Solutions.
NCT06078865 is a study of Osteoarthritis Shoulder and Rotator Cuff Syndrome of Shoulder and Allied Disorders that is actively recruiting participants, run by FX Shoulder Solutions. The registered enrollment target is 600 participants, above the 295-participant average among 8 other Osteoarthritis Shoulder trials with a reported enrollment target (103% higher). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06078865, a study of Osteoarthritis Shoulder and Rotator Cuff Syndrome of Shoulder and Allied Disorders, is actively recruiting participants, sponsored by FX Shoulder Solutions.
- RECRUITING
- Registry status
- 600 participants
- Enrollment target
- 4
- Study locations
Study Summary
Prospective Multi-Center Registry on study subjects with implanted devices marketed and legally commercialized in the USA by FX Shoulder Solutions.
Primary Outcome
Adjusted Constant Score that is ≥ 54 and improvement of ≥ 10 points from baseline. No continuous radiolucency or device migration/subsidence No revision surgery No serious device related adverse event.
Conditions Studied
Interventions
- DEVICE FX Artificial Shoulder Prosthesis
Study Locations (4)
Arizona
- OrthoArizona - Gilbert
Ohio
- First Settlement Orthopedics - Marietta
Rhode Island
- Orthopedics Rhode Island - Wakefield
Texas
- Texas Orthopedic Specialists - Bedford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2021-03-31 |
| Est. Completion | 2031-12-30 |
What NCT06078865 shows while recruiting
NCT06078865 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, above the 295-participant average among 8 other Osteoarthritis Shoulder trials with a reported enrollment target (103% higher).
The record links to 3 conditions, with Osteoarthritis Shoulder appearing as the primary indexed condition, and to 1 intervention - of which FX Artificial Shoulder Prosthesis is the first listed.
NCT06078865 reports a single indexed study location in Arizona, Ohio, Rhode Island.
Frequently Asked Questions
What is clinical trial NCT06078865 about?
NCT06078865 is a clinical study titled "FX Shoulder Prospective Clinical Study". Prospective Multi-Center Registry on study subjects with implanted devices marketed and legally commercialized in the USA by FX Shoulder Solutions.
What is the current status of trial NCT06078865?
This trial is currently recruiting. The enrollment target is 600 participants. The study started on 2021-03-31. Estimated completion is 2031-12-30.
What conditions does trial NCT06078865 study?
This clinical trial studies the following conditions: Osteoarthritis Shoulder, Rotator Cuff Syndrome of Shoulder and Allied Disorders, Fracture, Shoulder.
What interventions are being tested in trial NCT06078865?
The interventions under investigation include: FX Artificial Shoulder Prosthesis (DEVICE).
Who is sponsoring clinical trial NCT06078865?
This trial is sponsored by FX Shoulder Solutions, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06078865 being conducted?
This trial has 4 study locations across Arizona, Ohio, Rhode Island, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis Shoulder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06078865's enrollment target sits among peer trials
600 2nd of 8 higher than 6 of 8 other Osteoarthritis Shoulder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoarthritis Shoulder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
FX Shoulder Solutions Retrospective / Prospective Clinical Study
RECRUITING
-
The Effect of Micro Fragmented Adipose Tissue (MFAT) on Shoulder Osteoarthritis
RECRUITING · Phase 1
-
Embo Registry; National Registry for Artery Embolization
RECRUITING
-
Prophylactic Conjoint Tendon Lengthening During Reverse Shoulder Arthroplasty Outcomes
RECRUITING · NA
-
Perform Humeral System Study
RECRUITING
-
Catalyst CSR Shoulder System for Semi or Total Shoulder Arthroplasty
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI